✦ LIBER ✦

Gemtuzumab Ozogamicin is a promising post-remission therapy for acute myeloid leukemia

✍ Scribed by Abdul Rahman El Kinge; Hassan A. Hatoum; Rami A. Mahfouz; Zaher K. Otrock; Elias Jabbour; Hagop Kantarjian; Ali Bazarbachi

Book ID: 104040730
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 102 KB
Volume: 33
Category: Article
ISSN: 0145-2126
DOI: 10.1016/j.leukres.2008.05.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Low-dose Gemtuzumab-Ozogamicin as post-c

Low-dose Gemtuzumab-Ozogamicin as post-consolidation therapy in elderly patients with acute myeloid leukaemia: a pilot study

✍ Antonella Poloni; Debora Capelli; Silvia Trappolini; Benedetta Costantini; Mauro 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB

Gemtuzumab ozogamicin, mitoxantrone, and

Gemtuzumab ozogamicin, mitoxantrone, and etoposide in newly diagnosed acute myeloid leukemia patients with persistent leukemia after a course of induction therapy

✍ Michael Boyiadzis; Robert L. Redner; Anastasios Raptis; Jing-Zhou Hou; Mounzer A 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 71 KB

Azacitidine as the post-remission therap

Azacitidine as the post-remission therapy for elderly patients with acute myeloid leukemia

✍ Yamamoto, Ryusuke; Yokoyama, Akihiro; Yoneda, Mie; Ohashi, Kota; Hosoda, Toru; K 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 90 KB

Gemtuzumab Ozogamicin, A Potent and Sele

Gemtuzumab Ozogamicin, A Potent and Selective Anti-CD33 Antibody−Calicheamicin Conjugate for Treatment of Acute Myeloid Leukemia

✍ Hamann, Philip R.; Hinman, Lois M.; Hollander, Irwin; Beyer, Carl F.; Lindh, Del 📂 Article 📅 2002 🏛 American Chemical Society 🌐 English ⚖ 147 KB

Salvage therapy for acute myeloid leukem

Salvage therapy for acute myeloid leukemia with fludarabine, cytarabine, and idarubicin with or without gemtuzumab ozogamicin and with concurrent or sequential G-CSF

✍ Mike G. Martin; Kristan M. Augustin; Geoffrey L. Uy; John S. Welch; Lindsay Hlad 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB 👁 1 views

High-dose idarubicin plus busulfan as co

High-dose idarubicin plus busulfan as conditioning regimen to autologous stem cell transplantation: Promising post-remission therapy for acute myeloid leukemia in first complete remission?

✍ Hong, Ming; Miao, Kou-Rong; Zhang, Run; Lu, Hua; Liu, Peng; Xu, Wei; Chen, Li-Ju 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 224 KB